A section of Toxins (ISSN 2072-6651).
The “Bacterial Toxins” section of Toxins invites the submission of high quality manuscripts that report new investigations into all aspects of research on bacterial toxins, including but not limited to: mechanisms of toxin action; toxin transport or processing by host cells; host responses to bacterial toxins; novel properties of bacterial toxins; structure-function studies; mechanisms to detect and neutralize minute quantities of bacterial toxins; toxin evolution and classification; and clinical effects and case reports including applications of bacterial toxins as novel therapeutic compounds, and vaccine development and vaccine testing. The editors will also consider reviews that summarize current thinking or present controversial viewpoints for further discussion. Short communications that report important self-contained observations are also welcome.
adaptive immune response; animal modelling; antitoxins; apoptosis; biochemistry; bioinformatics; clinical laboratory; chemokines; clinical trials; cytokines: cytotoxicity; detection methods; diagnostic methods; environmental contaminants; ER stress; evolution; expression; gene expression profiling; inflammasome; intracellular transport; innate immune response; in vitro diagnostics; mechanism of action; molecular modelling; necrosis; next-generation sequencing; NMR; pattern recognition receptors; PCR; pathology; pathophysiology; peptides; pharmacology; pharmacokinetics; phylogeny; physiology; pore formation; protein; proteome; proteomics; purification; qPCR; RT-qPCR; pyroptosis; receptor analogues; receptor interaction; retrograde transport; ribotoxic stress response; taxonomy; therapeutic intervention; therapeutic molecules; toxin; toxinology; transcriptome; transcriptomics; unfolded protein response (UPR); vaccines; X-ray crystallography
Following special issues within this section are currently open for submissions:
- Anthrax Toxins (Deadline: 31 October 2015)
- Botulinum Toxin A on Lower Urinary Tract Dysfunction (Deadline: 31 January 2016)
- Clostridium difficile/Clostridium sordellii and Clostridium perfringens Toxins (Deadline: 29 February 2016)
- Contribution of Cytolethal Distending Toxin to Diseases Caused by Clinically-important Bacterial Pathogens (Deadline: 15 March 2016)
- Novel Pharmacological Inhibitors for Bacterial Protein Toxins (Deadline: 1 October 2016)
- Staphylococcus aureus Toxins (Deadline: 29 February 2016)
- Vacuolating Toxin (Deadline: 28 February 2016)
Following topical collections within this section are currently open for submissions:
Last update: 27 November 2013